City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Ryotaro Nakamura, MD  
Search results:  5  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-5 Trials Jump to page:

COH Protocol Number: 14155 ClinicalTrials.gov Number: NCT02151903

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  An Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine administered in Patients with B-cell Non-Hodgkin Lymphoma (NHL)

COH Protocol Number: 14115 ClinicalTrials.gov Number: NCT02195869

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  A Multicenter, Open-Label, Phase 1b/2 Study of Ibrutinib In Steroid Dependent or Refractory Chronic Graft Versus Host Disease

COH Protocol Number: 13377 ClinicalTrials.gov Number: NCT02016781

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: NCI Approved External Peer Review

Title:  BMT CTN 1102: A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Age 50-75 with Intermediate-2 and High Risk Myelodysplastic Syndrome.

COH Protocol Number: 12398 ClinicalTrials.gov Number: NCT01874288

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  A Phase I/II Study of De-Immunized DI-Leu16-IL2 Immunocytokine Administered Subcutaneously in Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

COH Protocol Number: 11274 ClinicalTrials.gov Number: NCT01295710

Principal Investigator: Ryotaro Nakamura, MD
Sponsor: Industrial

Title:  A Randomized, Prospective, Double Blind, Placebo-Controlled, Phase 3 Study of US-ATG-F Prophylaxis as a Supplement to Standard of Care Prophylaxis to Prevent Moderate to Severe Chronic GVHD in Adult Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome Patients after Allogeneic Stem Cell Transplantation from Unrelated Donors

 
Results per page: 25 50 100 All 1-5 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.